Pancreatic Cancer Research

ResearcherCharles UniversityActive in the last 2 years

Jan Bureš

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0326-117X; OpenAlex author ID A5039379035. Sources: ClinicalTrials.gov.

Their work

Papers
3 (first author 0, last author 1)
Trials
1
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 trial · 2026: 1 paper

Papers 3

  1. Prevalence of new onset diabetes mellitus among patients with pancreatic ductal adenocarcinoma: a population-based study Co-author DOI 10.64898/2026.08.05.26359758↗
  2. Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. Co-author DOI 10.3390/cancers15143669↗
  3. Pancreatic Adenocarcinoma: Epidemiology, Role of EUS in Diagnosis, Role of ERCP, Endoscopic Palliation. Last author DOI 10.14712/18059694.2020.1↗

Trials 1

  1. The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Dete… Study director NCT06807112↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kristýna Pončáková · 1 shared trial, 2025 · strength 0.80
  2. Jan Škrha · 2 shared papers, 2023–2026 · strength 0.46
  3. Miroslav Zavoral · 2 shared papers, 2023–2026 · strength 0.46
  4. Ondřej Májek · 1 shared paper, 2026 · strength 0.27
  5. Pavel Škrha · 1 shared paper, 2023 · strength 0.19
  6. Bohuš Bunganič · 1 shared paper, 2023 · strength 0.19
  7. Sameer Zar · 1 shared paper, 2019 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.